Research focus and expertise
The research activity of the Spleen, Red cell Aging & Transfusion group aims to develop a detailed molecular and cellular understanding of the physiological aging of mature red blood cells (RBCs), leading to their senescence and subsequent clearance from circulation by the spleen, a process which differs from the final elimination of nucleated eukaryotic cells that are not permanently circulating. This work has direct application in transfusion medicine, where the complex logistics of the transfusion chain are facilitated by the possibility of storing RBCs after blood collection. RBCs however continue to age during this period, leading to a degradation of their cellular properties. This degradation, or storage lesion, needs to be considered, and requires the management of post-transfusion complications such as reduced transfusion efficacy, which can ultimately lead to iron overload in chronically transfused patients. The knowledge generated our research is also relevant in a wide spectrum of pathophysiological contexts that cause anemia, such as hemoglobinopathies. Part of our research activity is conducted at the Imagine Institute (https://www.institutimagine.org/fr/olivier-hermine-181) where mouse models are developed to investigate RBC aging & clearance in vivo.
Proteins in mature, organelle-devoid RBCs experience oxidative damage during their lifespan; however, they cannot synthesize new proteins to replace damaged components. This observation is particularly relevant in the pathophysiological context of beta-thalassemia, where misfolded toxic alpha-globin chains accumulate leading to reduced circulation quality in vivo. Also, in transfusion medicine, donated RBCs prematurely age in vitro during refrigerated storage leading to reduced storage quality. Therefore, protein quality control mechanisms (e.g., amino acid repair, chaperone-mediated refolding, proteasomal degradation) enable RBCs to respond to these attacks and determine their fate. In particular, because ATP fuels protein quality control, RBCs must maintain ATP levels. Building on our novel findings regarding proteasomal function in RBC biology (Peltier, Marin et al., Journal of Clin Invest, 2025), we will study interactions between oxidative damage and protein quality control mechanisms in RBCs, in vivo and in vitro. Leveraging these findings will identify novel ways to maintain and improve RBC properties with the long-term goals of improving transfusion efficacy and reducing hemolysis in the physio-pathological context of beta-thalassemia.
In the context of transfusion medicine, RBCs are stored as RBC concentrates at 4°C in a storage solution (SAGM) for up to 6 weeks. In Europe, hemolysis is the only in vitro marker of storage quality required for any new storage process for RBC concentrates, and must be less than 0.8% at expiry. However, hemolysis is not correlated with transfusion recovery and therefore does not directly assess the cellular properties of RBCs that determine transfusion efficacy. Our recent work has demonstrated that quantification of Storage-induced MicroErythrocytes (SMEs) by imaging flow cytometry (Roussel, Morel, Dussiot et al., Blood, 2021) or flow cytometry (Marin et al., Front Physiol, 2022) is a physiologically-relevant in vitro marker since it directly quantifies the subpopulation of senescent RBCs that are preferentially cleared from the recipient circulation after transfusion.
This field of research is necessary to ensure a safe and efficient supply of RBC concentrates and to assess regulatory or technological evolutions. In addition, although each RBC concentrate is currently considered to be of equal quality, regardless of the donor or storage time, and can be used in all indications, progress in research would allow transfusion medicine to evolve towards personalized medicine.
Sandy Peltier, Mickaël Marin, Monika Dzieciatkowska, Michaël Dussiot, Micaela Kalani Roy, Johanna Bruce, Louise Leblanc, Youcef Hadjou, Sonia Georgeault, Aurélie Fricot, Camille Roussel, Daniel Stephenson, Madeleine Casimir, Abdoulaye Sissoko, François Paye, Safi Dokmak, Papa Alioune Ndour, Philippe Roingeard, Emilie-Fleur Gautier, Steven L Spitalnik, Olivier Hermine, Pierre A Buffet, Angelo D’Alessandro, Pascal Amireault
J Clin Invest, 135 (2025)
Although refrigerated storage slows the metabolism of volunteer donor RBCs, which is essential in transfusion medicine, cellular aging still occurs throughout this in vitro process. Storage-induced microerythrocytes (SMEs) are morphologically altered senescent RBCs that accumulate during storage and are cleared from circulation following transfusion. However, the molecular and cellular alterations that trigger clearance of this RBC subset remain to be identified. Using a staining protocol that sorts long-stored SMEs (i.e., CFSEhi) and morphologically normal RBCs (CFSElo), these in vitro aged cells were characterized. Metabolomics analysis identified depletion of energy, lipid-repair, and antioxidant metabolites in CFSEhi RBCs. By redox proteomics, irreversible protein oxidation primarily affected CFSEhi RBCs. By proteomics, 96 proteins, mostly in the proteostasis family, had relocated to CFSEhi RBC membranes. CFSEhi RBCs exhibited decreased proteasome activity and deformability; increased phosphatidylserine exposure, osmotic fragility, and endothelial cell adherence; and were cleared from the circulation during human spleen perfusion ex vivo. Conversely, molecular, cellular, and circulatory properties of long-stored CFSElo RBCs resembled those of short-stored RBCs. CFSEhi RBCs are morphologically and metabolically altered, have irreversibly oxidized and membrane-relocated proteins, and exhibit decreased proteasome activity. In vitro aging during storage selectively alters metabolism and proteostasis in these storage-induced senescent RBCs targeted for clearance.
Array
J Clin Invest, 2025, vol.135, p.
Sandy Peltier, Mickaël Marin, Monika Dzieciatkowska, Michaël Dussiot, Micaela Kalani Roy, Johanna Bruce, Louise Leblanc, Youcef Hadjou, Sonia Georgeault, Aurélie Fricot, Camille Roussel, Daniel Stephenson, Madeleine Casimir, Abdoulaye Sissoko, François Paye, Safi Dokmak, Papa Alioune Ndour, Philippe Roingeard, Emilie-Fleur Gautier, Steven L Spitalnik, Olivier Hermine, Pierre A Buffet, Angelo D’Alessandro, Pascal Amireault
Clément Derkenne, Manon Vavasseur, Olivier Javaudin, Yann Daniel, Simon-Pierre Corcostegui, Paul Lely, Elodie Ormes, Hélène Desudde, Sandrine Pons, Angela Giannuzzo, Matthieu Heidet, Philippe Vest, Daniel Jost, Michael Dussiot, Albane Miron de l’Espinay, Christophe Martinaud, Pascal Amireault
Sci Rep., 15 (2025)
European guidelines require packed red blood cells (pRBC) to be stored at 2–6 °C. However, negative temperature shifts can occur especially in prehospital transfusion. We investigated the impact of sub-zero temperature exposure on pRBC storage quality. At day 6 post donation (D6), three cohorts (14 pRBC) were put on a supercooled table for 10 h at either − 1 °C, -5 °C, and − 11 °C and compared to a control cohort. Hemolysis, pH and plasma biochemistry were evaluated weekly until D49. Storage-induced micro-erythrocytes (SMEs) were quantified as a surrogate marker for transfusion recovery. The primary endpoint was compliance with European storage standards at D42. The three sub-zero-exposed cohorts met standards at D42. Differences in hemolysis, pH, plasma biochemistry, or SMEs between exposed and control cohorts were non-statistically and/or non-clinically significant. Ten hours exposure to sub-zero temperatures down to -11 °C by conduction maintains storage quality of pRBCs, enabling a wiser risk assessment for potential transfusion use.
Array
Sci Rep., 2025, vol.15, p.
Clément Derkenne, Manon Vavasseur, Olivier Javaudin, Yann Daniel, Simon-Pierre Corcostegui, Paul Lely, Elodie Ormes, Hélène Desudde, Sandrine Pons, Angela Giannuzzo, Matthieu Heidet, Philippe Vest, Daniel Jost, Michael Dussiot, Albane Miron de l’Espinay, Christophe Martinaud, Pascal Amireault
Marin Mickaël, Roussel Camille, Dussiot Michael, Ndour Papa A, Hermine Olivier, Colin Yves, Gray Alan, Landrigan Matt, Le Van Kim Caroline, Buffet Pierre A, Amireault Pascal
Transfusion, 61 (2021)
[Red blood cells (RBC) change upon hypothermic conservation, and storage for 6 weeks is associated with the short-term clearance of 15% to 20% of transfused RBCs. Metabolic rejuvenation applied to RBCs before transfusion replenishes energetic sources and reverses most storage-related alterations, but how it impacts RBC circulatory functions has not been fully elucidated.,Six RBC units stored under blood bank conditions were analyzed weekly for 6 weeks and rejuvenated on Day 42 with an adenine-inosine-rich solution. Impact of storage and rejuvenation on adenosine triphosphate (ATP) levels, morphology, accumulation of storage-induced microerythrocytes (SMEs), elongation under an osmotic gradient (by LORRCA), hemolysis, and phosphatidylserine (PS) exposure was evaluated. The impact of rejuvenation on filterability and adhesive properties of stored RBCs was also assessed.,Rejuvenation of RBCs restored intracellular ATP to almost normal levels and decreased the PS exposure from 2.78% to 0.41%. Upon rejuvenation, the proportion of SME dropped from 28.2% to 9.5%, while the proportion of normal-shaped RBCs (discocytes and echinocytes 1) increased from 47.7% to 67.1%. In LORCCA experiments, rejuvenation did not modify the capacity of RBCs to elongate and induced a reduction in cell volume. In functional tests, rejuvenation increased RBC filterability in a biomimetic splenic filter (+16%) and prevented their adhesion to endothelial cells (-87%).,Rejuvenation reduces the proportion of morphologically altered and adhesive RBCs that accumulate during storage. Along with the improvement in their filterability, these data show that rejuvenation improves RBC properties related to their capacity to persist in circulation after transfusion.]
Array
Transfusion, 2021, vol.61, p.
Marin Mickaël, Roussel Camille, Dussiot Michael, Ndour Papa A, Hermine Olivier, Colin Yves, Gray Alan, Landrigan Matt, Le Van Kim Caroline, Buffet Pierre A, Amireault Pascal
Roussel Camille*, Morel Alexandre*, Dussiot Michaël*, Marin Mickaël, Colard Martin, Fricot-Monsinjon Aurélie, Martinez Anaïs, Chambrion Charlotte, Henry Benoît, Casimir Madeleine, Volle Geoffroy, Dépond Mallorie, Dokmak Safi, Paye François, Sauvanet Alain, Le Van Kim Caroline, Colin Yves, Georgeault Sonia, Roingeard Philippe, Spitalnik Steven L, Ndour Papa Alioune, Hermine Olivier, Hod Eldad A, Buffet Pierre A**, Amireault Pascal**
Blood, 137 (2021)
Permanent availability of red blood cells (RBCs) for transfusion depends on refrigerated storage, during which morphologically altered RBCs accumulate. Among these, a subpopulation of small RBCs, comprising type III echinocytes, spheroechinocytes, and spherocytes and defined as storage-induced microerythrocytes (SMEs), could be rapidly cleared from circulation posttransfusion. We quantified the proportion of SMEs in RBC concentrates from healthy human volunteers and assessed correlation with transfusion recovery, investigated the fate of SMEs upon perfusion through human spleen ex vivo, and explored where and how SMEs are cleared in a mouse model of blood storage and transfusion. In healthy human volunteers, high proportion of SMEs in long-stored RBC concentrates correlated with poor transfusion recovery. When perfused through human spleen, 15% and 61% of long-stored RBCs and SMEs were cleared in 70 minutes, respectively. High initial proportion of SMEs also correlated with high retention of RBCs by perfused human spleen. In the mouse model, SMEs accumulated during storage. Transfusion of long-stored RBCs resulted in reduced posttransfusion recovery, mostly due to SME clearance. After transfusion in mice, long-stored RBCs accumulated predominantly in spleen and were ingested mainly by splenic and hepatic macrophages. In macrophage-depleted mice, splenic accumulation and SME clearance were delayed, and transfusion recovery was improved. In healthy hosts, SMEs were cleared predominantly by macrophages in spleen and liver. When this well-demarcated subpopulation of altered RBCs was abundant in RBC concentrates, transfusion recovery was diminished. SME quantification has the potential to improve blood product quality assessment. This trial was registered at www.clinicaltrials.gov as #NCT02889133.
Array
Blood, 2021, vol.137, p.
Roussel Camille*, Morel Alexandre*, Dussiot Michaël*, Marin Mickaël, Colard Martin, Fricot-Monsinjon Aurélie, Martinez Anaïs, Chambrion Charlotte, Henry Benoît, Casimir Madeleine, Volle Geoffroy, Dépond Mallorie, Dokmak Safi, Paye François, Sauvanet Alain, Le Van Kim Caroline, Colin Yves, Georgeault Sonia, Roingeard Philippe, Spitalnik Steven L, Ndour Papa Alioune, Hermine Olivier, Hod Eldad A, Buffet Pierre A**, Amireault Pascal**
Roussel Camille, Monnier Sylvain, Dussiot Michael, Farcy Elisabeth, Hermine Olivier, Le Van Kim Caroline, Colin Yves, Piel Matthieu, Amireault Pascal, Buffet Pierre A
Frontiers in medicine, 5 (2018)
Red blood cells (RBC) ability to circulate is closely related to their surface area-to-volume ratio. A decrease in this ratio induces a decrease in RBC deformability that can lead to their retention and elimination in the spleen. We recently showed that a subpopulation of small RBC with reduced projected surface area accumulated upon storage in blood bank concentrates, but data on the volume of these altered RBC are lacking. So far, single cell measurement of RBC volume has remained a challenging task achieved by a few sophisticated methods some being subject to potential artifacts. We aimed to develop a reproducible and ergonomic method to assess simultaneously RBC volume and morphology at the single cell level. We adapted the fluorescence exclusion measurement of volume in nucleated cells to the measurement of RBC volume. This method requires no pre-treatment of the cell and can be performed in physiological or experimental buffer. In addition to RBC volume assessment, brightfield images enabling a precise definition of the morphology and the measurement of projected surface area can be generated simultaneously. We first verified that fluorescence exclusion is precise, reproducible and can quantify volume modifications following morphological changes induced by heating or incubation in non-physiological medium. We then used the method to characterize RBC stored for 42 days in SAG-M in blood bank conditions. Simultaneous determination of the volume, projected surface area and morphology allowed to evaluate the surface area-to-volume ratio of individual RBC upon storage. We observed a similar surface area-to-volume ratio in discocytes (D) and echinocytes I (EI), which decreased in EII (7%) and EIII (24%), sphero-echinocytes (SE; 41%) and spherocytes (S; 47%). If RBC dimensions determine indeed the ability of RBC to cross the spleen, these modifications are expected to induce the rapid splenic entrapment of the most morphologically altered RBC (EIII, SE, and S) and further support the hypothesis of a rapid clearance of the small RBC subpopulation by the spleen following transfusion.
Array
Frontiers in medicine, 2018, vol.5, p.
Roussel Camille, Monnier Sylvain, Dussiot Michael, Farcy Elisabeth, Hermine Olivier, Le Van Kim Caroline, Colin Yves, Piel Matthieu, Amireault Pascal, Buffet Pierre A
Address
Biotigr Lab
Team 4 UMR-S 1134 INSERM
Université de Paris
Hôpital NECKER – Enfants Malades
149 rue de Sèvres
75015 Paris, France